Vincerx Pharma, Inc. Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-04-03: Application 18698333; Invention COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDER; Applicant VINCERX PHARMA, INC.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-01-24: Application 18291834; Invention SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCER; Applicant VINCERX PHARMA, INC.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 18698333 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDER | VINCERX PHARMA, INC. VINCERX PHARMA GMBH | Abandoned -- Incomplete Application (Pre-examination) | US20240408222A1 | Hans-Georg LERCHEN Beatrix STELTE-LUDWIG Mareike WIEDMANN Andreas LERCHEN Anne-Sophie REBSTOCK Johannes KOEBBERLING Harvey WONG | Germany Germany Germany Germany France Germany Canada | |
| 2024-01-24 | 18291834 | SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCER | VINCERX PHARMA, INC. | Abandoned -- Incomplete Application (Pre-examination) | US20240325366A1 | Sooin HWANG Beatrix STELTE-LUDWIG | United States Germany |